Literature DB >> 28008594

Causes of death in critically ill multiple sclerosis patients.

A Karamyan1, H Brandtner2, S Grinzinger1, V Chroust1, C Bacher1, F Otto1, M Reisp1, L Hauer3, J Sellner1,4.   

Abstract

BACKGROUND: Patients with multiple sclerosis (MS) experience higher mortality rates as compared to the general population. While the risk of intensive care unit (ICU) admission is also reported to be higher, little is known about causes of death CoD in critically ill MS patients. AIM: To study the causes of death (CoD) in the series of critically ill patients with MS verified by autopsy.
METHODS: We reviewed hospital electronic charts of MS patients treated at the neurological ICU of a tertiary care hospital between 2000 and 2015. We compared clinical and pathological CoD for those who were autopsied.
RESULTS: Overall, 10 patients were identified (seven female; median age at death 65 years, range 27-80), and six of them were autopsied. The median MS duration prior to ICU admission was 27.5 years (range 1-50), and the median EDSS score at the time of ICU admission was 9 (range 5-9.5). The median length of ICU stay was 3 days (range 2-213). All the individuals in our series had experienced respiratory insufficiency during their ICU stay. The autopsy examination of brain tissue did not reveal evidences of MS lesions in one patient. In another patient, Lewy bodies were found on brain immunohistochemistry.
CONCLUSION: Mortality in critically ill MS patients is largely driven by respiratory complications. Sporadic disparities between clinical and pathological findings can be expected.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  autopsy; causes of death; critical illness; multiple sclerosis

Mesh:

Year:  2016        PMID: 28008594     DOI: 10.1111/ane.12724

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  2 in total

Review 1.  Vitamin D Supplementation in Multiple Sclerosis: A Critical Analysis of Potentials and Threats.

Authors:  Julia Feige; Tobias Moser; Lara Bieler; Kerstin Schwenker; Larissa Hauer; Johann Sellner
Journal:  Nutrients       Date:  2020-03-16       Impact factor: 5.717

Review 2.  A global view of comorbidity in multiple sclerosis: a systematic review with a focus on regional differences, methodology, and clinical implications.

Authors:  Larissa Hauer; Julian Perneczky; Johann Sellner
Journal:  J Neurol       Date:  2020-07-27       Impact factor: 4.849

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.